@article{6eb794376f94463094828227c02719c5,
title = "Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients with Incident Diabetes: Predicting heARt FAilure in dIabeTes (PARFAIT)",
abstract = "OBJECTIVE Heart failure (HF) often develops in patients with diabetes and is recognized for its role in increased cardiovascular morbidity and mortality in this population. Most existing models predict risk in patients with prevalent rather than incident diabetes and fail to account for sex differences in HF risk factors. We derived sex-specific models in Ontario, Canada to predict HF at diabetes onset and externally validated these models in the U.K. RESEARCH DESIGN AND METHODS Retrospective cohort study using international population-based data. Our derivation cohort comprised all Ontario residents aged ≥18 years who were diagnosed with diabetes between 2009 and 2018. Our validation cohort comprised U.K. patients aged ≥35 years who were diagnosed with diabetes between 2007 and 2017. Primary outcome was incident HF. Sex-stratified multivariable Fine and Gray subdistribution hazard models were constructed, with death as a competing event. RESULTS A total of 348,027 Ontarians (45% women) and 54,483 U.K. residents (45% women) were included. At 1, 5, and 9 years, respectively, in the external validation cohort, the C-statistics were 0.81 (95% CI 0.79-0.84), 0.79 (0.77-0.80), and 0.78 (0.76-0.79) for the female-specific model; and 0.78 (0.75-0.80), 0.77 (0.76-0.79), and 0.77 (0.75-0.79) for the male-specific model. The models were well-calibrated. Age, rurality, hypertension duration, hemoglobin, HbA1c, and cardiovascular diseases were common predictors in both sexes. Additionally, mood disorder and alcoholism (heavy drinker) were female-specific predictors, while income and liver disease were male-specific predictors. CONCLUSIONS Our findings highlight the importance of developing sex-specific models and represent an important step toward personalized lifestyle and pharmacologic prevention of future HF development.",
keywords = "diabetes, heart failure, sex-stratified prediction models, long-term outcomes",
author = "Sun, {Louise Y.} and Zghebi, {Salwa S} and {Bader Eddeen}, Anan and Liu, {Peter P.} and Lee, {Douglas S.} and Karen Tu and Tobe, {Sheldon W.} and Evan Kontopantelis and Mamas Mamas",
note = "Funding Information: This study was supported by the Canadian Institutes of Health Research. L.Y.S. was named National New Investigator by the Heart and Stroke Foundation of Canada and is supported by a Tier 2 Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa. D.S.L. is supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation. K.T. received a research scholar award from the Department of Family and Community Medicine at the University of Toronto. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care. Parts of this material are based on data and information compiled and provided by the CIHI. The authors acknowledge that the clinical registry data used in this analysis are from participating hospitals through CorHealth Ontario, which serves as an advisory body to the MOH, is funded by the MOH, and is dedicated to improving the quality, efficiency, access, and equity in the delivery of the continuum of adult cardiac and stroke care in Ontario, Canada. The U.K. cohort study was funded by the National Institute for Health Research School for Primary Care Research. The analyses, conclusions, opinions and statements expressed in this study are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Funding Information: The analyses, conclusions, opinions, and statements expressed in the manuscript are those of the authors and do not necessarily reflect those of the above agencies. Funding. This study was supported by the Canadian Institutes of Health Research. L.Y.S. was named National New Investigator by the Heart and Stroke Foundation of Canada and is supported by a Tier 2 Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa. D.S.L. is supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation. K.T. received a research scholar award from the Department of Family and Community Medicine at the University of Toronto. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care. Parts of this material are based on data and information compiled and provided by the CIHI. The authors acknowledge that the clinical registry data used in this analysis are from participating hospitals through CorHealth Ontario, which serves as an advisory body to the MOH, is funded by the MOH, and is dedicated to improving the quality, efficiency, access, and equity in the delivery of the continuum of adult cardiac and stroke care in Ontario, Canada. The U.K. cohort study was funded by the National Institute for Health Research School for Primary Care Research. Publisher Copyright: {\textcopyright} 2022 by the American Diabetes Association.",
year = "2022",
month = sep,
day = "27",
doi = "10.2337/dc22-0894",
language = "English",
volume = "45",
pages = "2737--2745",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "11",
}